DoctorsProofNPPES directory · verify at state boards

Pulmonary Disease in Live Oak, TX

5 verified pulmonary disease doctors in Live Oak.

Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the Texas Medical Board

Dr. Muhammad Talib, MD

Pulmonary Disease

20 yrs NPPES
NPI 1700855640
11901 TOEPPERWEIN RD STE 1401, Live Oak, TX 78233(210) 599-1433
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $849.75 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$849.75

Total received

51

Transactions

17

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$290.06
AstraZeneca Pharmaceuticals LP$61.53
Grifols USA, LLC$58.67
Boehringer Ingelheim Pharmaceuticals, Inc.$57.21
Jazz Pharmaceuticals Inc.$51.12
Electromed, Inc.$48.67

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 78th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Muhammad Talib do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Juan Garcia, MD

Pulmonary Disease

20 yrs NPPES
NPI 1104856400
12709 TOEPPERWEIN RD, SUITE 201, Live Oak, TX 78233(210) 655-6400
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $453.85 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$453.85

Total received

22

Transactions

5

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$157.73
Inari Medical, Inc.$139.64
Boehringer Ingelheim Pharmaceuticals, Inc.$105.25
AstraZeneca Pharmaceuticals LP$31.46
Itamar Medical Inc$19.77

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 72th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Juan Garcia do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Stephen Im, MD

Pulmonary Disease

20 yrs NPPES
NPI 1336163054
12500 JUDSON RD STE 205, Live Oak, TX 78233(210) 655-6400
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $464.75 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$464.75

Total received

26

Transactions

7

Paying companies

Top paying companies

Boehringer Ingelheim Pharmaceuticals, Inc.$173.91
GlaxoSmithKline, LLC.$156.82
Philips North America LLC$48.53
AstraZeneca Pharmaceuticals LP$31.46
Monaghan Medical Corporation$21.44
Itamar Medical Inc$19.77

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 73th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Stephen Im do not imply any wrongdoing. Many are meals, education, or research support.

Dr. John Stupka, MD

Pulmonary Disease

20 yrs NPPES
NPI 1407936024
12709 TOEPPERWEIN RD, 201, Live Oak, TX 78233(210) 655-6400
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $475.54 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$475.54

Total received

24

Transactions

8

Paying companies

Top paying companies

Boehringer Ingelheim Pharmaceuticals, Inc.$253.59
GlaxoSmithKline, LLC.$79.90
Philips North America LLC$48.55
Pulmonx Corporation$22.48
Monaghan Medical Corporation$21.43
Itamar Medical Inc$19.77

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 73th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to John Stupka do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Robert Winsett, DO

Pulmonary Disease

13 yrs NPPES
NPI 1841633153
12709 TOEPPERWEIN RD STE 201, Live Oak, TX 78233(713) 655-6400
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $282.19 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$282.19

Total received

14

Transactions

4

Paying companies

Top paying companies

Boehringer Ingelheim Pharmaceuticals, Inc.$135.52
GlaxoSmithKline, LLC.$76.69
Philips North America LLC$48.55
Monaghan Medical Corporation$21.43

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 68th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Robert Winsett do not imply any wrongdoing. Many are meals, education, or research support.

Pulmonary Disease in Live Oak, TX — Verified | DoctorsProof | DoctorsProof